Invesque Shares Rise on Buyout by Major Shareholder Magnetar

By Adriano Marchese

Shares in real estate investment firm Invesque rose after it agreed to be taken private by its controlling shareholder Magnetar Financial, in a transaction valuing the healthcare real estate firm's publicly traded equity at about $84.1 million.

Shares rose 37% to 13 Canadian cents a share (9 cents).

Under the terms of the arrangement, a special purpose entity managed by asset management firm Magnetar will acquire all of the issued and outstanding common shares in Invesque at 10.1 U.S. cents a share.

The consideration price represents a 68% premium on a spot basis, the company said, and a 30% premium to the volume-weighted average trading price of the shares for the last 20 days ended Sept. 29.

Shares in the company have been under pressure in 2026, falling about 37% since the start of the year to 10 Canadian cents. The shares are down from a 52-week high of C$0.17.

Magnetar owns about 88% of the shares of the company, according to FactSet.

The move follows the launch of a special committee by Invesque to evaluate a potential go-private deal with Magnetar after years of asset sales and debt reductions. The Toronto-listed firm said the buyout offers minority holders an immediate liquidity exit given thin public trading volumes.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

October 01, 2026 12:17 ET (16:17 GMT)